Basic Information
RNALocate ID: RLID:11001465
RNA Symbol: hsa-miR-203a-3p
Localization: Microvesicle
RNA Information
RNA Name: hsa-miR-203a-3p
RNA ID: miRBase:MIMAT0000264
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 25330373
Tissue/Cell Line: Colon cancer cell line (LIM1863)
Method: qRT-PCR|RNA sequencing
Description: To assess whether some miRNAs are specifically sorted into EVs we conducted a miRNA-enrichment analysis for A33-Exos, EpCAM-Exos and sMVs. MiRNAs with <2 fold changes relative to CL miRNAs were filtered out, yielding 63 miRNAs for comparison (Table 2). Data are collected from Table 2.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:11001461 Exosome Brain tissue 23382797
RLID:11001462 Exosome Plasma 23663360
RLID:11001463 Exosome Colon cancer cell line (LIM1863) 25330373
RLID:11001464 Microvesicle Follicular fluid 23666971
RLID-D:11000055 Exosome Blood|Breast tissue|Colon tissue|Seminal fluid|Tongue tissue
RLID-D:11000325 Microvesicle Breast cell line|Colon cancer cell line (LIM1863)|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-203a-3p Multiple sclerosis chronic progressive MNDR-E-MI-26706
MNDR hsa-miR-203a-3p Oral squamous cell carcinoma MNDR-E-MI-26707
MNDR hsa-miR-203a-3p Medulloblastoma MNDR-E-MI-26708
MNDR hsa-miR-203a-3p Small intestinal neuroendocrine tumor MNDR-E-MI-26709
MNDR hsa-miR-203a-3p High-grade serous ovarian carcinoma MNDR-E-MI-26710
MNDR hsa-miR-203a-3p Ovarian clear cell carcinoma MNDR-E-MI-26711
MNDR hsa-miR-203a-3p Uterine corpus endometrial carcinoma MNDR-E-MI-26712
MNDR hsa-miR-203a-3p Lymphoma MNDR-E-MI-26713
MNDR hsa-miR-203a-3p Cutaneous t cell lymphoma MNDR-E-MI-26714
MNDR hsa-miR-203a-3p Estrogen-receptor positive breast cancer MNDR-E-MI-26715
MNDR hsa-miR-203a-3p Estrogen-receptor negative breast cancer MNDR-E-MI-26716
MNDR hsa-miR-203a-3p Progesterone-receptor positive breast cancer MNDR-E-MI-26717
MNDR hsa-miR-203a-3p Progesterone-receptor negative breast cancer MNDR-E-MI-26718
MNDR hsa-miR-203a-3p Her2-receptor positive breast cancer MNDR-E-MI-26719
MNDR hsa-miR-203a-3p Breast cancer luminal MNDR-E-MI-26720
MNDR hsa-miR-203a-3p Bone disease MNDR-E-MI-26721
MNDR hsa-miR-203a-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-26722
MNDR hsa-miR-203a-3p Neurofibromatosis 1 MNDR-E-MI-26723
MNDR hsa-miR-203a-3p Small intestine cancer MNDR-E-MI-26724
MNDR hsa-miR-203a-3p Prostate cancer MNDR-E-MI-26725
MNDR hsa-miR-203a-3p Gastric cancer MNDR-E-MI-26726
MNDR hsa-miR-203a-3p Alzheimer disease MNDR-E-MI-26727
MNDR hsa-miR-203a-3p Urinary bladder cancer MNDR-E-MI-26728
MNDR hsa-miR-203a-3p Dysautonomia familial MNDR-E-MI-26729
MNDR hsa-miR-203a-3p Polycystic ovary syndrome MNDR-E-MI-26730
MNDR hsa-miR-203a-3p Cardiovascular disease MNDR-E-MI-26731
MNDR hsa-miR-203a-3p Uterine fibroid MNDR-E-MI-26732
MNDR hsa-miR-203a-3p Lung cancer MNDR-E-MI-26733
MNDR hsa-miR-203a-3p Endometrial cancer MNDR-E-MI-26734
MNDR hsa-miR-203a-3p Parkinson disease MNDR-E-MI-26735
MNDR hsa-miR-203a-3p Basal-like breast cancer MNDR-E-MI-26736
MNDR hsa-miR-203a-3p Thyroid cancer MNDR-E-MI-26737
MNDR hsa-miR-203a-3p Malignant mesothelioma MNDR-E-MI-26738
MNDR hsa-miR-203a-3p Pancreatic cancer MNDR-E-MI-26739
MNDR hsa-miR-203a-3p Melanoma MNDR-E-MI-26740
MNDR hsa-miR-203a-3p Rectum adenocarcinoma MNDR-E-MI-26741
MNDR hsa-miR-203a-3p Nephroblastoma MNDR-E-MI-26742
MNDR hsa-miR-203a-3p Colon cancer MNDR-E-MI-26743
MNDR hsa-miR-203a-3p Essential thrombocythemia MNDR-E-MI-26744
MNDR hsa-miR-203a-3p Ischemic attack transient MNDR-E-MI-26745
MNDR hsa-miR-203a-3p Colon adenocarcinoma MNDR-E-MI-26746
MNDR hsa-miR-203a-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-26747
MNDR hsa-miR-203a-3p Ovarian cancer MNDR-E-MI-26748
MNDR hsa-miR-203a-3p Prostate adenocarcinoma MNDR-E-MI-26749
MNDR hsa-miR-203a-3p Carcinoma ductal breast MNDR-E-MI-26750
MNDR hsa-miR-203a-3p Glioblastoma MNDR-E-MI-26751
MNDR hsa-miR-203a-3p Astrocytoma MNDR-E-MI-26752
MNDR hsa-miR-203a-3p Glioma MNDR-E-MI-26753
MNDR hsa-miR-203a-3p Chronic obstructive pulmonary disease MNDR-E-MI-26754
MNDR hsa-miR-203a-3p Atopic dermatitis MNDR-E-MI-26755
MNDR hsa-miR-203a-3p Epilepsy temporal lobe MNDR-E-MI-26756
MNDR hsa-miR-203a-3p Osteosarcoma MNDR-E-MI-26757
MNDR hsa-miR-203a-3p Breast carcinoma MNDR-E-MI-26758
MNDR hsa-miR-203a-3p Pancreatic ductal adenocarcinoma MNDR-E-MI-26759
MNDR hsa-miR-203a-3p Uterine cancer MNDR-E-MI-26760
MNDR hsa-miR-203a-3p Skin disease MNDR-E-MI-26761
MNDR hsa-miR-203a-3p Cervical adenocarcinoma MNDR-E-MI-26762
MNDR hsa-miR-203a-3p Gastric adenocarcinoma MNDR-E-MI-26763
MNDR hsa-miR-203a-3p Cervical squamous cell carcinoma MNDR-E-MI-26764
MNDR hsa-miR-203a-3p Lung squamous cell carcinoma MNDR-E-MI-26765
MNDR hsa-miR-203a-3p Carcinoma lung non-small-cell MNDR-E-MI-26766
MNDR hsa-miR-203a-3p Lung adenocarcinoma MNDR-E-MI-26767
MNDR hsa-miR-203a-3p Thyroid carcinoma MNDR-E-MI-26768
MNDR hsa-miR-203a-3p Ovarian carcinoma MNDR-E-MI-26769
MNDR hsa-miR-203a-3p Bladder urothelial carcinoma MNDR-E-MI-26770
MNDR hsa-miR-203a-3p Pancreatic adenocarcinoma MNDR-E-MI-26771
MNDR hsa-miR-203a-3p Carcinoma renal cell MNDR-E-MI-26772
MNDR hsa-miR-203a-3p Kidney renal papillary cell carcinoma MNDR-E-MI-26773
MNDR hsa-miR-203a-3p Renal clear cell carcinoma MNDR-E-MI-26774
MNDR hsa-miR-203a-3p Esophageal cancer MNDR-E-MI-26775
MNDR hsa-miR-203a-3p Lung small cell carcinoma MNDR-E-MI-26776
MNDR hsa-miR-203a-3p Head and neck squamous cell carcinoma MNDR-E-MI-26777
MNDR hsa-miR-203a-3p Testicular germ cell cancer MNDR-E-MI-26778
MNDR hsa-miR-203a-3p Oral submucous fibrosis MNDR-E-MI-26779
MNDR hsa-miR-203a-3p Breast invasive carcinoma MNDR-E-MI-26780
MNDR hsa-miR-203a-3p Hepatocellular carcinoma MNDR-E-MI-26781
MNDR hsa-miR-203a-3p B-cell lymphoma MNDR-E-MI-26782
MNDR hsa-miR-203a-3p Rheumatoid arthritis MNDR-E-MI-26783
MNDR hsa-miR-203a-3p Neuroblastoma MNDR-E-MI-26784
MNDR hsa-miR-203a-3p Barrett's adenocarcinoma MNDR-E-MI-26785
MNDR hsa-miR-203a-3p Gastroesophageal reflux disease MNDR-E-MI-26786
MNDR hsa-miR-203a-3p Chronic myeloid leukemia MNDR-E-MI-26787
MNDR hsa-miR-203a-3p Ulcerative colitis MNDR-E-MI-26788
MNDR hsa-miR-203a-3p Tonsil cancer MNDR-E-MI-26789
MNDR hsa-miR-203a-3p Psoriasis MNDR-E-MI-26790
MNDR hsa-miR-203a-3p Skin cutaneous melanoma MNDR-E-MI-26791
MNDR hsa-miR-203a-3p Skin melanoma MNDR-E-MI-26792
MNDR hsa-miR-203a-3p Acute myeloid leukemia MNDR-E-MI-26793
MNDR hsa-miR-203a-3p Colorectal cancer MNDR-E-MI-26794
MNDR hsa-miR-203a-3p Nasopharyngeal carcinoma MNDR-E-MI-26795
MNDR hsa-miR-203a-3p Nasopharynx carcinoma MNDR-E-MI-26796
MNDR hsa-miR-203a-3p Multiple myeloma MNDR-E-MI-26797
MNDR hsa-miR-203a-3p Uterine cervical neoplasms MNDR-E-MI-26798
MNDR hsa-miR-203a-3p Ependymoma MNDR-E-MI-26799
MNDR hsa-miR-203a-3p Nasopharyngeal cancer MNDR-E-MI-26800
MNDR hsa-miR-203a-3p Nerve degeneration MNDR-E-MI-26801
MNDR hsa-miR-203a-3p Prostatic neoplasms MNDR-E-MI-26802
MNDR hsa-miR-203a-3p Non-alcoholic fatty liver disease MNDR-E-MI-26803
MNDR hsa-miR-203a-3p Barrett's carcinogenesis MNDR-E-MI-26804
MNDR hsa-miR-203a-3p Duke C MNDR-E-MI-26805
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABCE1 Homo sapiens RR00024333
TOP